Practice-changing data in endometrial cancer support checkpoint inhibitor–chemotherapy combinations, extending ...
Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be ...
Cancer treatment has changed dramatically over the past decade. What was once dominated by extensive surgeries followed by aggressive chemotherapy and radiation has now evolved into a more balanced, ...
A new nanovaccine—a type of vaccine that uses tiny particles for a more targeted delivery to the immune system—could offer a “dual blow” against cancer. This is the finding of researchers from the ...
Aug. 4 (UPI) --Findings from a study in mice suggest that using a common artificial sweetener, sucralose, could hamper certain immunotherapy treatments in cancer patients. However, for folks reluctant ...
The combination of belzutifan plus lenvatinib significantly improved outcomes for patients with clear cell renal cell carcinoma who progressed following immunotherapy compared with cabozantinib ...
DOCTOR, SEVERAL NEW TREATMENTS ARE REVOLUTIONIZING THE FIGHT AGAINST BREAST CANCER AND CHIEF OF MEDICAL ONCOLOGY AT MERCY MEDICAL CENTER, DOCTOR DAVID REISBERG IS JOINING US NOW WITH SOME MORE ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...